RP59500 (Quinupristin/dalfopristin): Three case reports of its use in infection due to Enterococcus faecium

Journal of Infection

Volumn 36, Issue 3, 1998, Pages 324-327

  Cassell, J ^a   Balakrishnan, I ^a   Samarasinghe, D ^a   Mistry, P ^a   Prentice, H G ^a   Gillespie, S H ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AMINOTRANSFERASE; BILIRUBIN; DALFOPRISTIN PLUS QUINUPRISTIN; STREPTOGRAMIN;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; CAUSE OF DEATH; DRUG EFFICACY; DRUG SAFETY; ENTEROCOCCUS FAECALIS; ENZYME DEFECT; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; IMMUNE DEFICIENCY; INJECTION; MALE; STREPTOCOCCUS INFECTION; SUPERINFECTION;

EID: 0031864541     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(98)94495-4     Document Type: Article

References (21)

1. Anonymous. Vancomycin resistant enterococci. CDR Weekly 1996; 6: 267.
2. Heath CH, Blackmore TK, Gordon DL. Emerging resistance in Enterococcus spp. Med J Aust 1996; 164: 116-120.
3. Spera RV Jr, Farber BF. Multidrug resistant E. faecium. An untreatable nosocomial pathogen. Drugs 1994; 48: 678-688.
4. Shay DK, Goldmann DA, Jarvis WR. Reducing the spread of anti-microbial-resistant micro-organisms. Control of vancomycin-resistant enterococci. Pediatr Clin North Am 1995; 42: 703-716.
5. Nicoletti G, Stefani S. Enterococci: susceptibility patterns and therapeutic options. Eur J Clin Microbiol Infect Dis 1995; 14 (Suppl. 1): S33-37.
6. Vemuri RK, Zervos MJ. Enterococcal infections. The increasing threat of nosocomial spread. Postgrad Med 1993; 93: 121-124, 127-128.
7. Barriere JC, Paris JM. RP-59500 and related semisynthetic streptogramins. Drugs of the Future 1993; 18: 833-845.
8. Bernard P, Risse L, Bonnetblanc JM. Treatment of acute dermohypodermal infections by pristinamycin - an open study of 42 patients. Ann Dermatol Venereol 1996; 123: 16-20.
9. Poilane I, Fawaz F, Nathanson M et al. Corynebacterium diptheriae osteomyelitis in an immunocompetent child - a case report. Eur J Pediatric 1995; 154: 381-383.
10. Aidan P, Francois M, Prunel M, Narcy P. Periorbital and orbital cellulitis in children. Arch Pediatric 1994; 1: 879-885.
11. Bigen E, Bourrillon A. Resistant pneumococci in Pediatrics - therapeutic indications. Presse Med 1995; 24: 137.
12. Burucoa C. Pasdelcoup T, Chapon C, Fouchere JL, Robert R. Failure of pristinamycin treatment in a case of pneumococcal pneumonia. Eur J Clin Microbiol Infect Dis 1995; 14: 341-342.
13. Chant C, Rybak MJ. Quinupristin/Dalfopristin (RP-59500) - a new streptogramin antibiotic. Ann Pharmacother 1995; 29: 1022-1027.
14. Low D. Quinupristin/Dalfopristin: spectrum of activity, pharmacokinetics and initial clinical experience. Microb Drug Resist 1995; 1: 223-234.
15. Griswold MW, Lomaestro BM, Briceland LL. Quinupristin-dalfopristin (RP 59500): an injectable streptogramin combination. Am J Health Syst Pharm 1996; 53: 2045-2053.
16. Chant C, Rybak MJ. Quinupristin/dalfopristin (RP 59500): a new sreptogramin antibiotic. Ann Pharmacother 1995; 29: 1022-1027.
17. Bernard E, Bensoussan M, Bensoussan F et al. Pharmacokinetics and suction blister fluid penetration of a semisynthetic injectable streptogramin RP 59500 (RP 57669/RP 54476). Eur J Clin Microbiol Infect Dis 1994; 13: 768-771.
18. Etienne SD, Montay G, Le Liboux A, Frydman A, Garaud JJ. A phase 1, double-blind, placebo-controlled study of the tolerance and pharmacokinetic behaviour of RP 59500. J Antimicrob Chemother 1992; 30 (Suppl. A): 123-131.
19. Michel M, Dompmartin A, Szczurko C, Castel B, Moreau A, Leroy D. Eczematous-like drug eruption induced by synergistins. Contact Dermatitis 1996; 34: 86-87.
20. Watine J, Gineston JL, Bruna T, Dubourdieu B, Lamblin G. Acute haemorrhagic colitis associated with antibiotics - responsibility of Klebsiella oxytoca in association with Clostridium difficile. Medecine et maladies infectieuses 1994; 24: 635-637.
21. Lynn WA, Clutterbuck E, Want S et al. Treatment of CAPD-peritonitis due to glycopeptide-resistant E. faecium with quinupristin/dalfopristin. Lancet 1994; 344: 1025-1026.